Johnson & Johnson (JNJ) Stock: Surges as J&J Offers $5.5 Billion Talc Settlement to End Cancer Lawsuits

  TLDR JNJ offers $5.5B settlement covering about 76,000 talc cancer claims. JNJ stock rises after proposed deal targets long-running talc litigation. Settlement needs 95% claimant approval before becoming final. Company expects to pay $3 billion in 2027 with more due in 2028. Proposal resolves existing claims but leaves future lawsuits unaffected. Johnson & Johnson [...]

The post Johnson & Johnson (JNJ) Stock: Surges as J&J Offers $5.5 Billion Talc Settlement to End Cancer Lawsuits appeared first on Blockonomi.